|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||
| Cash and cash equivalents | |||||
| Prepaid assets | |||||
| Total current assets | |||||
| Investments and cash held in Trust Account | |||||
| Total assets | |||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||
| Current liabilities: | |||||
| Accrued expenses, formation and offering costs | |||||
| Accrued expenses | |||||
| State franchise tax accrual | |||||
| Public warrants derivative liability | |||||
| Public Warrants | |||||
| Private Placement Warrants | |||||
| Notes and advances payable - related party | |||||
| Total current liabilities | |||||
| Deferred underwriting compensation | |||||
| Total liabilities | |||||
| Class A subject to possible redemption, 80,000,000 shares at March 31, 2022 and December 31, 2021 (at redemption value of $10 per share) | |||||
| Stockholders’ deficit: | |||||
| Common stock value | |||||
| Accumulated deficit | |||||
| Class A Common Stock | |||||
| Class F Common Stock | |||||
| Total stockholders’ deficit | |||||
| Total liabilities and stockholders’ deficit |
Loading...
